TR200000444T2 - 3-Aril-süksinamido-hidroksamik asitler, üretim yöntemleri ve bu maddeleri içeren farmasötik terkipler. - Google Patents

3-Aril-süksinamido-hidroksamik asitler, üretim yöntemleri ve bu maddeleri içeren farmasötik terkipler.

Info

Publication number
TR200000444T2
TR200000444T2 TR2000/00444T TR200000444T TR200000444T2 TR 200000444 T2 TR200000444 T2 TR 200000444T2 TR 2000/00444 T TR2000/00444 T TR 2000/00444T TR 200000444 T TR200000444 T TR 200000444T TR 200000444 T2 TR200000444 T2 TR 200000444T2
Authority
TR
Turkey
Prior art keywords
succinamido
aryl
substances
pharmaceutical compositions
compositions containing
Prior art date
Application number
TR2000/00444T
Other languages
English (en)
Inventor
Grams Frank
Zimmermann Gerd
Will Krell Hans
Menta Ernesto
Leinert Herbert
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of TR200000444T2 publication Critical patent/TR200000444T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

R,R1,R5 ve R6'nin istemlerdeki anlamlara sahip oldugu formül (I)'in bilesikleri, genel formül (I)'in bilesikleri içindeki canli organizmalarda metabolize olan farmakolojik olarak uygun tuzlar, esterler ve bunlarin türevleri.
TR2000/00444T 1997-08-19 1998-08-18 3-Aril-süksinamido-hidroksamik asitler, üretim yöntemleri ve bu maddeleri içeren farmasötik terkipler. TR200000444T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97114255A EP0897908A1 (de) 1997-08-19 1997-08-19 3-Aryl-Succinamido-Hydroxamsäuren, Prozesse zu ihrer Herstellung und diese Substanzen enthaltende Medikamente

Publications (1)

Publication Number Publication Date
TR200000444T2 true TR200000444T2 (tr) 2000-07-21

Family

ID=8227237

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00444T TR200000444T2 (tr) 1997-08-19 1998-08-18 3-Aril-süksinamido-hidroksamik asitler, üretim yöntemleri ve bu maddeleri içeren farmasötik terkipler.

Country Status (14)

Country Link
US (1) US6576628B1 (tr)
EP (2) EP0897908A1 (tr)
JP (1) JP2001515061A (tr)
KR (1) KR20010023025A (tr)
CN (1) CN1276786A (tr)
AR (1) AR020310A1 (tr)
AT (1) ATE226933T1 (tr)
AU (1) AU747536B2 (tr)
BR (1) BR9811954A (tr)
CA (1) CA2300912A1 (tr)
DE (1) DE59806128D1 (tr)
TR (1) TR200000444T2 (tr)
WO (1) WO1999009003A1 (tr)
ZA (1) ZA987412B (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051998A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
EP1169031A1 (en) * 1999-04-09 2002-01-09 British Biotech Pharmaceuticals Limited Antimicrobial agents
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US8088737B2 (en) 2003-04-04 2012-01-03 Incyte Corporation Compositions, methods and kits relating to Her-2 cleavage
CA3100276A1 (en) 2018-06-06 2019-12-12 Massachusetts Institute Of Technology Circular rna for translation in eukaryotic cells
WO2020237227A1 (en) 2019-05-22 2020-11-26 Massachusetts Institute Of Technology Circular rna compositions and methods
AU2020397956A1 (en) 2019-12-04 2022-07-07 Orna Therapeutics, Inc. Circular RNA compositions and methods
US12297285B2 (en) 2022-06-24 2025-05-13 Orna Therapeutics, Inc. Circular RNA encoding chimeric antigen receptors targeting BCMA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds
DE69502378T2 (de) * 1994-01-20 1998-10-01 British Biotech Pharm Metalloproteinaseinhibitoren
GB9401129D0 (en) * 1994-01-21 1994-03-16 British Bio Technology Hydroxamic acid derivatives as metalloproteinase inhibitors

Also Published As

Publication number Publication date
AR020310A1 (es) 2002-05-08
DE59806128D1 (de) 2002-12-05
AU747536B2 (en) 2002-05-16
EP1005449B1 (de) 2002-10-30
ZA987412B (en) 2000-02-18
BR9811954A (pt) 2000-08-22
KR20010023025A (ko) 2001-03-26
EP1005449A1 (de) 2000-06-07
AU9344098A (en) 1999-03-08
ATE226933T1 (de) 2002-11-15
JP2001515061A (ja) 2001-09-18
CN1276786A (zh) 2000-12-13
WO1999009003A1 (de) 1999-02-25
US6576628B1 (en) 2003-06-10
CA2300912A1 (en) 1999-02-25
EP0897908A1 (de) 1999-02-24

Similar Documents

Publication Publication Date Title
TR200000289T2 (tr) Kimyasal bileşimler
AU7576896A (en) Lipopolyamines as transfection agents and their pharmaceutical applications
TW289757B (tr)
DK0758248T3 (da) Formuleringer til faktor IX
TR199802289A2 (tr) Fosfonasit-ikame etmis benzazepinon-n-asetikasit türevleri.
DE59702414D1 (de) Dipeptidische benzamidine als kininogenasen-inhibitoren
TR200201168T2 (tr) CGRP-Antagonistleri-yeni siklopropanlar içeren ilaçlar ve üretim yöntemleri.
TR199900636T2 (tr) Anti-tümör ajanlari olarak ikameli/katkili heterosaykillar.
FI933902A0 (fi) Substituerade cyklohexanderivat foer behandling av sjukdomar
ATE273281T1 (de) Heterozyklische cytotoxische wirkstoffe
TR200000444T2 (tr) 3-Aril-süksinamido-hidroksamik asitler, üretim yöntemleri ve bu maddeleri içeren farmasötik terkipler.
ATE297904T1 (de) Halo-alkoxycarbonylverbindungen
ATE265455T1 (de) Tetrahydropyridoverbindungen
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
MX9708735A (es) Benzotiazoles y benzoxazoles, composiciones farmaceuticas que contienen estos compuestos y su uso y proceso para prepararlos.
CA2098842A1 (en) Use of host cell phospholipids for inhibiting microbial colonization
TR200000637T2 (tr) Benzoksazin ve benzotiazin türevleri ve bunların ilaçlarda kullanımı.
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
PT1017681E (pt) Derivados de hidrazono-benzazuleno composicoes farmaceuticas e intermediarios
TR200200017T2 (tr) Benzofuran türevleri
DE59404784D1 (de) Neue carbonsäureester von 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren herstellung sowie deren verwendung
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
ATE243698T1 (de) 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate
DE50100396D1 (de) (+)- und (-)-2-Cyclododecylpropanol und (+)- und (-)-2-Cyclododecylpropionsäure sowie deren Herstellung und Verwendung
TR199701011A2 (tr) 1-karba-(detia)-sefalosforin türevleri.